CIDRAP newsletters options
A randomized control trial shows that being exposed to misinformation about the COVID-19 vaccine induced a decline in the intent to definitely get the COVID vaccine of 6.2 percentage points in the United Kingdom and 6.4 percentage points in the United States, according to a study today in Nature Human Behaviour.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A multifaceted intervention implemented in a Japanese emergency department was associated with reduced antibiotic prescribing at discharge and an increase in appropriate prescribing, Japanese researchers reported today in Infection Control and Hospital Epidemiology.
Patients on long-term dialysis were also more than 5 times likelier to be infected.
Also, a UK group adds more evidence that the B117 variant is about a third deadlier.
Though per capita antibiotic use in LMICs is lower than in wealthier nations, rates are converging.
States continue to struggle with how best to reach the elderly and minorities, groups at greater risk for severe COVID-19.
Except for a slight decrease from Mar 29 to Apr 11, 2020, emergency department (ED) visits involving drug and opioid overdoses (ODs) were 1% to 45% more frequent than in 2019, according to a JAMA Psychiatry study published yesterday.
An international team of researchers has identified a new and always lethal neurologic disease in chimpanzees living in a sanctuary in Sierra Leone. The scientists, including researchers from the University of Wisconsin-Madison, reported their findings yesterday in Nature Communications.
People age 35 to 49 have especially contributed to recent outbreaks.
Findings suggest the vaccine provides strong protection after 1 dose and could slow disease spread.
Though US numbers have fallen, the CDC head warns they are overall still very high.
Higher viral loads of SARS-CoV-2, the virus that causes COVID-19, are associated with an increased risk of transmission, according to cohort study results from Catalonia, Spain, published yesterday in The Lancet Infectious Diseases,
CARB-X announced today that it is awarding up to $6.4 million to French biopharmaceutical firm Mutabilis to develop a new class of antibiotics to treat infections caused by carbapenem-resistant Enterobacterales (CRE) bacteria.
Researchers find some B117 variants with the E484K mutation tied to vaccine resistance, and data raise red flags about vaccine protection.
Also, vaccine doses sent to states will rise from 10 million to 10.5 million.
CDC researchers recommend improving racial data tracking and health workers' uptake.
"Another vaccine can now join the fight to reduce the incidence of COVID-19."
An assessment of 90 Veterans Health Administration (VHA) hospitals found that carbapenem-specific stewardship strategies were associated with a lower volume of carbapenem use and more appropriate carbapenem prescribing, researchers reported yesterday in the Journal of Antimicrobial Chemotherapy.
Recovered COVID-19 patients given a single dose of a currently authorized mRNA vaccine had a robust immune response equal to or exceeding that reached by their coronavirus-naïve peers after the second dose, according to a non–peer reviewed study published yesterday on the medRxiv preprint server.
"The maximum public health benefit would come from giving a single dose to as many people as possible."
